These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6205564)

  • 1. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a norepinephrine uptake inhibitor, in endogenous depression: clinical and biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Adv Biochem Psychopharmacol; 1984; 39():439-47. PubMed ID: 6205564
    [No Abstract]   [Full Text] [Related]  

  • 2. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet serotonin uptake inhibition as a basis for monitoring antidepressant drug treatment.
    Lingjaerde O
    J Clin Psychopharmacol; 1984 Apr; 4(2):76-81. PubMed ID: 6231316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
    Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant effect of femoxetine and desipramine and relationship to the concentration of amine metabolites in cerebrospinal fluid. A double-blind evaluation.
    Dahl LE; Lundin L; le Fèvre Honoré P; Dencker SJ
    Acta Psychiatr Scand; 1982 Jul; 66(1):9-17. PubMed ID: 6181653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A
    Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of zimeldine in Alzheimer's disease. Cognitive and biochemical measures.
    Cutler NR; Haxby J; Kay AD; Narang PK; Lesko LJ; Costa JL; Ninos M; Linnoila M; Potter WZ; Renfrew JW
    Arch Neurol; 1985 Aug; 42(8):744-8. PubMed ID: 2411246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crossover study of zimelidine and desipramine in depression: evidence for amine specificity [proceedings].
    Potter WZ; Calil HM; Extein I; Muscettola G; Goodwin FK
    Psychopharmacol Bull; 1981 Jan; 17(1):26-9. PubMed ID: 6453356
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obsessive-compulsive disorder and serotonin: is there a connection?
    Insel TR; Mueller EA; Alterman I; Linnoila M; Murphy DL
    Biol Psychiatry; 1985 Nov; 20(11):1174-88. PubMed ID: 2413912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
    Aberg-Wistedt A; Jostell KG; Ross SB; Westerlund D
    Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of zimelidine and desipramine in endogenous depression.
    Lingjaerde O; Bratfos O; Bratlid T; Haug JO
    Acta Psychiatr Scand; 1983 Jul; 68(1):22-30. PubMed ID: 6225313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological specificity is not the same as clinical selectivity.
    Montgomery SA; James D; Montgomery DB
    Psychopharmacol Ser; 1987; 3():179-83. PubMed ID: 2434946
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPS, HIAA, and HVA levels of cerebrospinal fluid.
    Przuntek H; Kuhn W
    Adv Neurol; 1990; 53():445-9. PubMed ID: 1700583
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical studies on norepinephrine metabolism: how to interpret the numbers.
    Linnoila M; Guthrie S; Lane EA; Karoum F; Rudorfer M; Potter WZ
    Psychiatry Res; 1986 Mar; 17(3):229-39. PubMed ID: 2939486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal responses to zimelidine and desipramine in depressed patients.
    Calil HM; Lesieur P; Gold PW; Brown GM; Zavadil AP; Potter WZ
    Psychiatry Res; 1984 Nov; 13(3):231-42. PubMed ID: 6098913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alaproclate a novel antidepressant? A biochemical and clinical comparison with zimeldine.
    Aberg-Wistedt A; Alvariza M; Bertilsson L; Malmgren R; Wachtmeister H
    Acta Psychiatr Scand; 1985 Mar; 71(3):256-68. PubMed ID: 2580422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of chronic alprazolam on sleep and bioamine metabolites in depression.
    Zarcone VP; Benson KL; Greene KA; Csernansky JG; Faull KF
    J Clin Psychopharmacol; 1994 Feb; 14(1):36-40. PubMed ID: 7512100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between zimelidine and desipramine in endogenous depression. A cross-over study.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Aug; 66(2):129-38. PubMed ID: 6215831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients.
    Linnoila M; Karoum F; Calil HM; Kopin IJ; Potter WZ
    Arch Gen Psychiatry; 1982 Sep; 39(9):1025-8. PubMed ID: 6214234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.